Evidence map›Paper›PMID 23136204›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2012

CD8+ T cell-derived IFN-γ prevents infection by a second heterologous virus.

Laura Valentine, Rashaun Potts, Mary Premenko-Lanier

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 9 citations in OpenAlex.

  1. IL-21 controls CD8Zoological research · 2026
    Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Laura ValentineDivision of Experimental Medicine, University of California San Francisco, San Francisco, CA 94110, USA.
Rashaun Potts
Mary Premenko-Lanier
University of California, San Francisco · USSan Francisco State University · US

Funding

SFSU MBRS - RISER25GM059298 · NIGMS · SAN FRANCISCO STATE UNIVERSITY · PI BAIRD, TEASTER T, BAYLISS, FRANK T · 1999 to 2021
$21.0M
MOLECULAR AND CELLULAR IMMUNOLOGYT32AI007334 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CYSTER, JASON G · 1988 to 2023
$11.0M
Preventing and Curing Persistent Infections with Transient FTY720 TreatmentR00AI076346 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI PREMENKO-LANIER, MARY F · 2009 to 2010
$498k
NIAID NIH HHS R00 AI076346NIAID NIH HHS R00 AI076346-01NIAID NIH HHS T32 AI007334NIAID NIH HHS T32AI007334NIGMS NIH HHS R25 GM059298NIGMS NIH HHS R25-GM059298
6 · The paper itself

Abstract

Persistent viral infection is often associated with dysfunctional immune responses against unrelated pathogens. Lymphocytic choriomeningitis virus (LCMV) can establish acute or chronic infections in mice and is widely used as a model for persistent virus infections in humans. Mice infected with LCMV develop a transient defect in Ag-specific immunity against heterologous viral infection. Although it has been proposed that LCMV infection induces an immunosuppressed state within the host, our data show that infected mice successfully clear vaccinia virus through a mechanism that involves CD8(+) T cell-derived IFN-γ. This observation demonstrates that chronic LCMV infection does not impair protective immunity against heterologous viral challenge. Rather, a natural sterilizing immunity is induced following a primary infection that prevents a secondary infection. Our findings suggest a need to re-evaluate current thoughts about the immune suppression that might occur during a persistent infection.

Indexed as

Acute DiseaseAnimalsCD8-Positive T-LymphocytesChronic DiseaseFemaleHeLa CellsHumansInterferon-gammaLymphocytic ChoriomeningitisLymphocytic choriomeningitis virusMaleMiceMice, Inbred C57BLMice, KnockoutVacciniaVaccinia virusInterferon-gamma

Identifiers

PMID23136204
PMCPMC3518669
OpenAlexW2137824403

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.